General Information of the Compound
Compound ID
CP0407998
Compound Name
4-[methyl(nonyl)amino]-N-quinolin-3-ylbenzamide
    Show/Hide
Synonyms
4-(methyl(nonyl)amino)-N-(quinolin-3-yl)benzamide
CHEMBL407233
SCHEMBL846831
    Show/Hide
Structure
Formula
C26H33N3O
Molecular Weight
403.57
Canonical SMILES
CCCCCCCCCN(C)c1ccc(cc1)C(=O)Nc1cnc2ccccc2c1
    Show/Hide
InChI
InChI=1S/C26H33N3O/c1-3-4-5-6-7-8-11-18-29(2)24-16-14-21(15-17-24)26(30)28-23-19-22-12-9-10-13-25(22)27-20-23/h9-10,12-17,19-20H,3-8,11,18H2,1-2H3,(H,28,30)
    Show/Hide
InChIKey
KGQMIDBMCJPWMX-UHFFFAOYSA-N
Physicochemical Property
logP
6.6739
Rotatable Bonds
11
Heavy Atom Count
30
Polar Areas
45.23
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44450300
ChEMBL ID
CHEMBL407233
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
2
Ki = 23 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-(methyl(nonyl)amino)-N-(quinolin-3-yl)benzamide )
Drug Name 4-(methyl(nonyl)amino)-N-(quinolin-3-yl)benzamide
Target(s)
Transient receptor potential cation channel V1 (TRPV1)
Inhibitor